Correlation Between Agenus and United Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Agenus and United Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Agenus and United Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Agenus Inc and United Therapeutics, you can compare the effects of market volatilities on Agenus and United Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Agenus with a short position of United Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Agenus and United Therapeutics.

Diversification Opportunities for Agenus and United Therapeutics

-0.62
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Agenus and United is -0.62. Overlapping area represents the amount of risk that can be diversified away by holding Agenus Inc and United Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on United Therapeutics and Agenus is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Agenus Inc are associated (or correlated) with United Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of United Therapeutics has no effect on the direction of Agenus i.e., Agenus and United Therapeutics go up and down completely randomly.

Pair Corralation between Agenus and United Therapeutics

Given the investment horizon of 90 days Agenus Inc is expected to under-perform the United Therapeutics. In addition to that, Agenus is 3.18 times more volatile than United Therapeutics. It trades about -0.12 of its total potential returns per unit of risk. United Therapeutics is currently generating about 0.11 per unit of volatility. If you would invest  36,140  in United Therapeutics on August 31, 2024 and sell it today you would earn a total of  1,673  from holding United Therapeutics or generate 4.63% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Agenus Inc  vs.  United Therapeutics

 Performance 
       Timeline  
Agenus Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Agenus Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
United Therapeutics 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in United Therapeutics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak technical indicators, United Therapeutics may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Agenus and United Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Agenus and United Therapeutics

The main advantage of trading using opposite Agenus and United Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Agenus position performs unexpectedly, United Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in United Therapeutics will offset losses from the drop in United Therapeutics' long position.
The idea behind Agenus Inc and United Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments